Literature DB >> 27906837

Different impacts of hypertension and diabetes mellitus on all-cause and cardiovascular mortality in community-dwelling older adults: the Rancho Bernardo Study.

Jee-Young Oh1, Matthew A Allison, Elizabeth Barrett-Connor.   

Abstract

OBJECTIVES: Although the prevalence rates of hypertension (HTN) and diabetes mellitus are slowing in some high-income countries, HTN and diabetes mellitus remain as the two major risk factors for atherosclerotic cardiovascular disease (CVD), the leading cause of death in the United States and worldwide. We aimed to observe the association of HTN and diabetes mellitus with all-cause and CVD mortality in older white adults.
METHODS: All community-dwelling Rancho Bernardo Study participants who were at least 55 years old and had carefully measured blood pressure and plasma glucose from 75-g oral glucose tolerance test at the baseline visit (1984-1987, n = 2186) were followed up until death or the last clinic visit in 2013 (median 14.3 years, interquartile range 8.4-21.3).
RESULTS: In unadjusted analyses, diabetes mellitus was associated with all-cause mortality [hazard ratio 1.40, 95% confidence interval (CI) 1.23-1.60] and CVD mortality (hazard ratio 1.67, 95% CI 1.39-2.00); HTN with all-cause mortality [hazard ratio 1.93 (1.73-2.15)] and CVD mortality [hazard ratio 2.45 (2.10-2.93)]. After adjustment for cardiovascular risk factors, including age, BMI, triglycerides, HDL-cholesterol, smoking, exercise, and alcohol consumption, diabetes mellitus was associated with CVD mortality only (hazard ratio 1.25, P = 0.0213). Conversely, HTN was associated with both all-cause (hazard ratio 1.34, P < 0.0001) and CVD mortality (hazard ratio 1.40, P = 0.0003). Having both diabetes mellitus and HTN was associated with all-cause (hazard ratio 1.38, P = 0.0002) and CVD mortality (hazard ratio 1.70, P < 0.0001).
CONCLUSION: We report the novel finding that HTN is more strongly associated with all-cause and CVD mortality than diabetes mellitus. Having both confers a modest increase in the hazards for these types of mortality.

Entities:  

Mesh:

Year:  2017        PMID: 27906837     DOI: 10.1097/HJH.0000000000001145

Source DB:  PubMed          Journal:  J Hypertens        ISSN: 0263-6352            Impact factor:   4.844


  12 in total

1.  Different combinations of glucose tolerance and blood pressure status and incident cardiovascular disease and all-cause mortality events.

Authors:  M A Hajebrahimi; S Akbarpour; A Eslami; F Azizi; F Hadaegh
Journal:  J Hum Hypertens       Date:  2017-07-27       Impact factor: 3.012

2.  Deaths from total and premature cardiovascular disease associated with high normal blood pressure and hypertension in rural Chinese men and elderly people.

Authors:  Leilei Liu; Yu Liu; Yongcheng Ren; Yang Zhao; Pei Qin; Dechen Liu; Xu Chen; Cheng Cheng; Feiyan Liu; Chunmei Guo; Qionggui Zhou; Quanman Li; Gang Tian; Minghui Han; Ranran Qie; Xiaoyan Wu; Shengbing Huang; Xinping Luo; Ruirong Cheng; Dongsheng Hu; Jian Wang; Ming Zhang
Journal:  J Hum Hypertens       Date:  2020-07-20       Impact factor: 3.012

3.  Prevalence and Predictors of Co-occurring Hypertension and Depression Among Community-Dwelling Older Adults.

Authors:  Cicily A Gray; Omar T Sims; Hyejung Oh
Journal:  J Racial Ethn Health Disparities       Date:  2020-01-03

4.  Trends in the prevalence of metabolic syndrome and its components in South Korea: Findings from the Korean National Health Insurance Service Database (2009-2013).

Authors:  Seung Eun Lee; Kyungdo Han; Yu Mi Kang; Seon-Ok Kim; Yun Kyung Cho; Kyung Soo Ko; Joong-Yeol Park; Ki-Up Lee; Eun Hee Koh
Journal:  PLoS One       Date:  2018-03-22       Impact factor: 3.240

5.  Multi-state analysis of hypertension and mortality: application of semi-Markov model in a longitudinal cohort study.

Authors:  Azra Ramezankhani; Michael J Blaha; Mohammad Hassan Mirbolouk; Fereidoun Azizi; Farzad Hadaegh
Journal:  BMC Cardiovasc Disord       Date:  2020-07-06       Impact factor: 2.298

6.  A cross-sectional study of the ambulatory central artery stiffness index in patients with hypertension.

Authors:  Xuezhai Zeng; Na Jia; Deping Liu; Lijuan Wang; Zhujin Xu; Yan Zhang; Hua Wang; Ruisheng Zhang; Jihong Zhou; Chunyu Pan; Yu Gan; Weiwei Qiao
Journal:  Medicine (Baltimore)       Date:  2019-06       Impact factor: 1.817

7.  Impact Of Hypertension versus Diabetes on Cardiovascular and All-cause Mortality in Iranian Older Adults: Results of 14 Years of Follow-up.

Authors:  Neda Zafari; Samaneh Asgari; Mojtaba Lotfaliany; Amirreza Hadaegh; Fereidoun Azizi; Farzad Hadaegh
Journal:  Sci Rep       Date:  2017-10-27       Impact factor: 4.379

8.  Exploration and Validation of the Performance of Hemoglobin A1c in Detecting Diabetes in Community-Dwellers With Hypertension.

Authors:  Shanhu Qiu; Ziwei Du; Wei Li; Juan Chen; Hang Wu; Jingbao Liu; Min Cai; Bei Wang; Haijian Guo; Zilin Sun
Journal:  Ann Lab Med       Date:  2020-06-17       Impact factor: 3.464

9.  Potentially inappropriate medication use among hypertensive older African-American adults.

Authors:  Mohsen Bazargan; James L Smith; Ebony O King
Journal:  BMC Geriatr       Date:  2018-10-05       Impact factor: 3.921

10.  Group-Based Trajectory Modeling to Identify Patterns of Adherence and Its Predictors Among Older Adults on Angiotensin-Converting Enzyme Inhibitors (ACEIs)/Angiotensin Receptor Blockers (ARBs).

Authors:  Rutugandha Paranjpe; Michael L Johnson; Ekere J Essien; Jamie C Barner; Omar Serna; Esteban Gallardo; Zahra Majd; Marc L Fleming; Nancy Ordonez; Marcia M Holstad; Susan M Abughosh
Journal:  Patient Prefer Adherence       Date:  2020-10-13       Impact factor: 2.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.